Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome

Liver Transplantation

Volumn 14, Issue 2, 2008, Pages 144-150

  Ulrich, Frank ^a   Pratschke, Johann ^a   Neumann, Ulf ^a   Pascher, Andreas ^a   Puhl, Gero ^a   Fellmer, Peter ^a   Weiss, Sascha ^a   Jonas, Sven ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APROTININ; AZATHIOPRINE; BASILIXIMAB; BLOOD CLOTTING FACTOR 5 LEIDEN; CALCINEURIN INHIBITOR; CYCLOSPORIN; DACLIZUMAB; HEPARIN; HYDROXYUREA; LEPIRUDIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENPROCOUMON; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; BUDD CHIARI SYNDROME; CHRONIC DISEASE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENE MUTATION; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; HEPARIN INDUCED THROMBOCYTOPENIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOSIS; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; BUDD-CHIARI SYNDROME; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMORRHAGE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PORTAL VEIN; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 39449121650     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21282     Document Type: Article

References (32)

1. Singh V, Sinha SK, Nain CK, Bambery P, Kaur U, Verma S, et al. Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 2000; 15:550-554.
2. Olzinski AT, Sanyal AJ. Treating Budd-Chiari syndrome: making rational choices from a myriad of options. J Clin Gastroenterol 2000;30:155-161.
3. McCarthy PM, van Heerden JA, Adson MA, Schafer LW, Wiesner RH. The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg 1985; 120: 657-662.
4. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/ or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55:878-884.
5. Klein AS. Management of Budd-Chiari syndrome. Liver Transpl 2006:12(Suppl 2):S23-S28.
6. Bachet JB, Condat B, Hagege H, Plessier A, Consigny Y, Belghiti J, Valla D. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007;46:60-68.
7. Klein AS, Molmenti EP. Surgical treatment of Budd-Chiari syndrome. Liver Transpl 2003;9:891-896.
8. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990;211:43-49.
9. Srinivasan P. Rela M. Prachalias A, Muiesan P, Portmann B, Mufti GJ, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002;73:973-977.
10. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403.
11. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-371.
12. Ahn SS, Yellin A, Sheng FC, Colonna JO, Goldstein LI, Busuttil RW. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management. J Vasc Surg 1987;5:28-37.
13. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M. Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-89.
14. Pisani-Ceretti A, Intra M, Prestipino F, Ballarini C, Cordovana A, Santambrogio R, Spina GP. Surgical and radiologic treatment of primary Budd-Chiari syndrome. World J Surg 1998;22:48-53; discussion 53-44.
15. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 2000;232:340-352.
16. Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg 2001;233:522-527.
17. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-508.
18. Olliff SP. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome. Eur J Gastroenterol Hepatol 2006;18:1151-1154.
19. Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999;44:568-574.
20. Smalberg JH, Murad SD, Braakman E, Valk PJ, Janssen HL, Leebeek FW. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica 2006;91:1712-1713.
21. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O'Grady J, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 2006:44:520-528.
22. Colak Y, Karasu Z, Oruc N, Can C, Balym Z, Akarca U, et al. Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol 2006; 18:917-920.
23. Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001;48:264-268.
24. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308-1316.
25. Knoop M, Lang M, Neumann U, Bechstein WO, Neuhaus P. [Treatment of advanced Budd-Chiari syndrome by liver transplantation]. Chirurg 1998;69:1362-1368. [German]
26. Ulrich F, Steinmuller T, Lang M, Settmacher U, Muller AR, Jonas S, et al. Liver transplantation in patients with advanced Budd-Chiari syndrome. Transplant Proc 2002;34: 2278.
27. Putnam CW, Porter KA, Weil R 3rd, Reid HA, Starzl TE. Liver transplantation of Budd-Chiari syndrome. JAMA 1976;236:1142-1143.
28. Jamieson NV, Williams R, Calne RY. Liver transplantation for Budd-Chiari syndrome, 1976-1990. Ann Chir 1991; 45:362-365.
29. Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992; 174:453-459.
30. Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995;21:1337-1344.
31. Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant 2005; 19:501-506.
32. Melear JM, Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation 2002;74: 1090-1095.